Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

221.45
+1.770.81%
Post-market: 221.10-0.3500-0.16%18:09 EDT
Volume:3.99M
Turnover:885.04M
Market Cap:391.39B
PE:93.83
High:224.37
Open:221.09
Low:220.32
Close:219.68
52wk High:244.81
52wk Low:164.39
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.61
T/O Rate:0.23%
Dividend:6.65
Dividend Rate:3.00%
EPS(TTM):2.36
EPS(LYR):2.36
ROE:6225.00%
ROA:9.81%
PB:-119.69
PE(LYR):93.83

Loading ...

AbbVie EVP, GC and Secretary Perry C. Siatis Disposes of Common Shares

Reuters
·
Feb 28

Aldeyra FY 2025 R&D expense falls 46.8% to USD 25.7 million

Reuters
·
Feb 28

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

AbbVie Inc Stock Closed Up by 3.12% on Feb 27: What Signal Does It Send?

TradingKey
·
Feb 28

Richter posts Q4 Clean EBIT HUF 92bn (+37%)

Reuters
·
Feb 27

AbbVie Announces $7.5 Billion Senior Notes Offering

TIPRANKS
·
Feb 27

AbbVie launches $8.0 billion senior notes offering

Reuters
·
Feb 27

Basilea Pharmaceutica AG Publishes Investor Presentation on Anti-Infective Portfolio and Pipeline

Reuters
·
Feb 26

AbbVie Could See Continued Outperformance Despite Market Concerns, RBC Capital Markets Says

MT Newswires Live
·
Feb 26

AbbVie Initiated at Outperform by RBC Capital

Dow Jones
·
Feb 25

Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested

Benzinga_recent_news
·
Feb 25

BRIEF-Abbvie Files For Seven-Part Notes Offering Of Upto $8 Billion

Reuters
·
Feb 25

Abbvie: Files for Seven-Part Notes Offering of Upto $8 Bln - SEC Filing

THOMSON REUTERS
·
Feb 25

U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP

Reuters
·
Feb 25

AbbVie’s Real‑World Vraylar Study in Bipolar I Disorder Reaches Completion

TIPRANKS
·
Feb 25

AbbVie Plans to Launch Offering of Senior Notes

MT Newswires Live
·
Feb 24

Abbvie Files for Seven-Part Notes Offering, Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Feb 24

AbbVie to Present at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 24

ConvaTec FY25 adjusted diluted EPS rises 16% to 17.6 cents

Reuters
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24